Simone A.P. van Luxemburg-Heijs

Author

Also Known As

S A P van Luxemburg-Heijs, S. A. P. van Luxemburg-Heijs, S. A.P. van Luxemburg-Heijs, S.A.P. Luxemburg-Heijs, S.A.P. van Luxemburg-Heijs, S.A.P.van Luxemburg-Heijs, Simone A. P. van Luxemburg-Heijs, Simone A.P. Van Luxemburg-Heijs, Simone A.P. van Luxemburg-Heijs

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Europdonor Foundation Leiden University Medisch Spectrum Twente

About

Simone A.P. van Luxemburg-Heijs is an author at Leiden University Medical Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	570
2	Cell Biology	11	12	548
3	Blood Transplantation	2	2	85
4	Health Sciences	1	1	14
5	Allergy	1	1	99

Simone A.P. van Luxemburg-Heijs

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Liesbeth C. de Wreede, Journal of Clinical Investigation HistocompatibilityCell TherapyT Cell ReactivityT-regulatory CellImmunology	2017	99
Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene Cornelis A.M. van Bergen, Michel G.D. Kester, Inge Jedema, Blood	2007	86
High-Throughput Characterization of 10 New Minor Histocompatibility Antigens by Whole Genome Association Scanning Cornelis A.M. van Bergen, Caroline E. Rutten, Edith D. van der Meijden, Cancer Research HistocompatibilityHlaImmunologyPathologyAntigen Processing	2010	85
HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion Sanja Stevanović, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Blood	2013	79
Identification of phosphatidylinositol 4-kinase type II β as HLA class II-restricted target in graft versus leukemia reactivity Marieke Griffioen, Edith D. van der Meijden, Elisabeth H. Slager, Proceedings of the National Academy of Sciences HistocompatibilityCell TherapyHla ImmunogeneticsImmunologyPathology	2008	67
Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer Elisabeth H. Slager, M. Willy Honders, Edith D. van der Meijden, Blood	2006	65
Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells Freke M. Kloosterboer, Simone A.P. van Luxemburg-Heijs, RA van Soest, Leukemia HistocompatibilityCell TherapyTransplantationImmunologyHematology	2004	63
Generation of Donor-Derived Antileukemic Cytotoxic T-Lymphocyte Responses for Treatment of Relapsed Leukemia After Allogeneic HLA-Identical Bone Marrow Transplantation JH Falkenburg, Simone A.P. van Luxemburg-Heijs, M van den Elshout, Journal of Immunotherapy	1993	54
HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia Caroline E. Rutten, Simone A.P. van Luxemburg-Heijs, Marieke Griffioen, Leukemia HlaHistocompatibilityHematological MalignancyHuman Leukocyte AntigenMalignant Blood Disorder	2008	54
Patient HLA-DP–Specific CD4+ T Cells from HLA-DPB1–Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus-Host Disease Caroline E. Rutten, Simone A.P. van Luxemburg-Heijs, Constantijn J.M. Halkes, Biology of Blood and Marrow Transplantation Cell TherapyImmunologySevere GvhdPathologyImmunotherapy	2012	50

Page 1